CAMH.OB: Summary for CAMBRIDGE HEART INC - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 12:16am EST - Canadian Markets open in 9 hours and 14 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Cambridge Heart Inc. (CAMH.OB)

On Feb 9: 0.095 USD

0.008 (9.20%)

MORE ON CAMH.OB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

CAMBRIDGE HEART INC (OTC BB:CAMH.OB) Delayed quote data

Last Trade:	0.095 USD
Trade Time:	Feb 9
Change:	0.008 (9.20%)
Prev Close:	0.087
Open:	0.09
Bid:	0.095 x 5000
Ask:	0.10 x 5000
1y Target Est:	2.30

Day's Range:	0.09 - 0.10
52wk Range:	0.12 - 3.90
Volume:	496,048
Avg Vol (3m):	132,527
Market Cap:	6.17M
P/E (ttm):	N/A
EPS (ttm):	-0.133
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add CAMH.OB to Portfolio

Download Data

HEADLINES

•	CAMBRIDGE HEART INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
	EDGAR Online (Wed, Jan 6)

•	Cambridge Heart sheds two board seats
	at bizjournals.com (Mon, Jan 4)

•	Cambridge Heart Announces Changes to the Board of Directors
	Business Wire (Mon, Jan 4)

•	CAMBRIDGE HEART INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur
	EDGAR Online (Wed, Dec 30)

•	Cambridge Heart stock sale raises $1.8M
	at bizjournals.com (Tue, Dec 29)

•	Cambridge Heart Raises $1.8 Million in Private Placement
	Business Wire (Mon, Dec 28)

•	CAMBRIDGE HEART INC Financials
	EDGAR Online Financials (Sat, Nov 21)

•	Study Supports Use of MTWA Test as Predictor of Sudden Cardiac Death
	Business Wire (Wed, Nov 18)

•	Cambridge Heart Reports Results for the Third Quarter 2009
	Business Wire (Mon, Nov 16)

•	CAMBRIDGE HEART INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
	EDGAR Online (Mon, Nov 16)

More Headlines for CAMH.OB...

ANALYST

EPS Est (next year) (Dec-08) :	N/A
EPS Est (in 2 years) (Dec-09) :	N/A
Avg Rec (current)*:	3.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Cambridge Heart, Inc. engages in the research, development, and commercialization of products for the non-invasive diagnosis of cardiac disease in the United States and internationally.

Full Company Profile

Add to Portfolio

Email to a Friend

•